← Back to Search

Study Drug for Gastroparesis

Phase 2
Waitlist Available
Research Sponsored by Vanda Pharmaceuticals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Study Summary

This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States. One hundred fifty (150) subjects diagnosed with gastroparesis, who satisfy the selection criteria for the study, will be randomized to one of two treatment groups, active or placebo.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in gastroparesis associated symptoms as assessed by patient reported diary

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Study DrugExperimental Treatment1 Intervention
VLY-686 (Tradipitant) oral capsule for 4 weeks.
Group II: PlaceboPlacebo Group1 Intervention
Placebo oral capsule for 4 weeks.

Find a Location

Who is running the clinical trial?

Vanda PharmaceuticalsLead Sponsor
61 Previous Clinical Trials
19,254 Total Patients Enrolled
2 Trials studying Gastroparesis
250 Patients Enrolled for Gastroparesis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Indiana
Arizona
How old are they?
18 - 65
What site did they apply to?
Vanda Investigational Site
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
2016. "Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02970968.
All > Diabetic Gastroparesis > Gastroparesis
~18 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top